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ABSTRACT | Positive Expiratory Pressure (PEP) 
improves lung function, however, PEP-induced changes 
are not fully established. The aim of this study was to 
assess the acute effects of different PEP levels on chest 
wall volumes and the breathing pattern in children with 
Cystic Fibrosis (CF). Anthropometric data, lung function 
values, and respiratory muscle strength were collected. 
Chest wall volumes were assessed by Optoelectronic 
plethysmography at rest and during the use of different 
PEP levels (10 and 20 cm H2O), randomly chosen. Eight 
subjects with CF (5M, 11.5±3.2  years, 32±9.5  kilograms) 
and seven control subjects (4M, 10.7±1.5  years, 
38.2±7.8 kilograms) were recruited. The CF group showed 
significantly lower FEF values 25-75% (CF: 1.8±0.8 vs. CG: 
2.3±0.6) and FEV1/FVC ratio (CF: 0.8±0.1 vs. CG: 1±0.1) 
compared with the control group (p<0.05). Different 
PEP levels increased the usual volume in chest wall and 
its compartments in both groups; however, this volume 
was significantly higher in the control group compared 
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with the CF group during PEP20 (CW: 0.77±0.25  L vs. 
0.44±0.16 L; RCp: 0.3±0.13 L vs. 0.18±0.1 L; RCa: 0.21±0.1 L 
vs. 0.12±0.1 L; AB: 0.25±0.1 L vs. 0.15±0.1 L; p<0.05 for all 
variables). Minute ventilation was significantly higher 
during PEP compared with breathing at rest in both 
groups (p<0.005). End-expiratory volume was also 
higher during PEP compared with breathing at rest 
for chest wall and pulmonary rib cage in both groups 
(p<0.05). Different PEP levels may increase chest wall 
volumes in CF patients.
Keywords | Cystic Fibrosis; Respiratory Therapy; 
Respiratory System; Thoracic Wall.
RESUMO | Pressão Expiratória Positiva (PEwP) melhora a 
função pulmonar, entretanto, as mudanças induzidas pela PEP 
não estão totalmente estabelecidas. O objetivo do estudo foi 
avaliar os efeitos agudos de diferentes intensidades de PEP 
nos volumes da parede torácica (PT) e padrão respiratório em 
crianças com Fibrose Cística (FC). Dados antropométricos, 
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função pulmonar e força da musculatura respiratória. Os volumes da 
PT foram avaliados através da Pletismografia Optoeletrônica (POE) 
em repouso e durante o uso de diferentes intensidades de PEP (10 e 
20 cm H2O). Foram recrutados 8 sujeitos com FC (5H; 11,5 ± 3,2 anos; 
32 ± 9,5 kg) e 7 sujeitos (4H; 10,7 ±  1,5 anos; 38,2 ± 7,8 kg). Grupo 
FC mostrou valores significativamente menores para FEF 25-75% 
(FC: 1,8  ±  0,8 vs. GC: 2,3  ±  0,6) e relação VEF1/CVF (FC: 0,8  ±  0,1 
vs. GC: 1  ±  0,1) comparado ao grupo controle (p>0,05). Diferentes 
intensidades de PEP levaram a um aumento do volume corrente da PT 
e seus compartimentos em ambos os grupos, entretanto, este volume 
aumentou de forma significativa no grupo controle quando comparado 
ao grupo FC durante PEP20 (CW: 0,77 ± 0,25 L vs. 0,44 ± 0,16 L; RCp: 
0,3 ± 0,13 L vs. 0,18 ± 0,1 L; RCa: 0,21 ± 0,1 L vs. 0,12 ± 0,1 L; AB: 0,25 ± 0,1 L 
vs. 0,15 ± 0,1 L; p>0,05 para todas as variáveis). A ventilação minuto 
aumentou de forma significativa durante a PEP em comparação a 
respiração em repouso para ambos os grupos (p>0,005). Volume 
expiratório final também foi maior durante a PEP em comparação a 
respiração em repouso para PT e caixa torácica pulmonar em ambos 
os grupos (p>0,05). Diferentes intensidades de PEP podem induzir 
aumentos nos volumes da parede torácica em pacientes com FC.
Descritores | Fibrose Cística; Terapia Respiratória Sistema 
Respiratório; Parede Torácica.
RESUMEN | La Presión Espiratoria Positiva (PEP) mejora la función 
pulmonar, mientras tanto, los cambios inducidos por la PEP no 
están totalmente establecidos. El objetivo del estudio fue evaluar los 
efectos agudos de distintas intensidades de PEP en los volúmenes 
de la pared torácica (PT) y patrón respiratorio en niños con Fibrosis 
Cística (FC). Datos antropométricos, función pulmonar y fuerza de la 
musculatura respiratoria. Los volúmenes de la PT fueron evaluados 
a través de la Pletismografía Optoelectrónica (POE) en reposo y 
durante el uso de distintas intensidades de PEP (10 y 20 cm H2O). 
Fueron reclutados 8 sujetos con FC (5H; 11,5 ± 3,2 años; 32 ± 9,5 kg) 
y 7 sujetos (4H; 10,7  ±  1,5  años; 38,2  ±  7,8  kg). Grupo FC mostró 
valores significativamente menores para FEF 25-75% (FC: 1,8 ± 0,8 
vs. GC: 2,3 ± 0,6) y relación VEF1/CVF (FC: 0,8 ± 0,1 vs. GC: 1 ± 0,1) 
comparado al grupo control (p>0,05). Distintas intensidades de 
PEP conllevaron a un incremento del volumen corriente de la PT 
y sus compartimentos en ambos los grupos, mientras tanto, este 
volumen incrementó de manera significativa en el grupo control 
cuando comparado al grupo FC durante PEP20 (CW: 0,77 ± 0,25 L 
vs. 0,44 ± 0,16 L; RCp: 0,3 ± 0,13 L vs. 0,18 ± 0,1 L; RCa: 0,21 ± 0,1 L 
vs. 0,12 ± 0,1 L; AB: 0,25 ± 0,1 L vs. 0,15 ± 0,1 L; p>0,05 para todas las 
variables). La ventilación minuto incrementó de manera significativa 
durante la PEP en comparación a la respiración en reposo para ambos 
grupos (p>0,005). El volumen espiratorio final también fue más 
grande durante la PEP en comparación a la respiración en reposo 
para PT y la caja torácica pulmonar en ambos los grupos (p>0,05). 
Las distintas intensidades de PEP pueden inducir incrementos en los 
volúmenes de la pared torácica en pacientes con FC.
Palabras clave | Fibrosis Quística; Terapia Respiratoria; Sistema 
Respiratorio; Pared Torácica.
INTRODUCTION
Cystic Fibrosis (CF) is a multi-system, autosomal 
recessive genetic disease characterized by chromosomal 
alteration that leads to ionic imbalance, promoting 
changes in exocrine glands secretion and resulting in 
abnormal functioning of several organs and systems1. 
CF patients show lung disorders such as mucosal 
secretion dehydration and viscosity increase, which 
lead to the obstruction of the small airways and 
triggering of a chronic inflammatory process2. Several 
respiratory complications can occur in CF patients as 
bronchiolitis, bronchitis, atelectasis, bronchiectasis, 
pneumothorax, hemoptysis, recurrent pneumonia, cor 
pulmonale, and respiratory failure3. Therefore, due to 
the pathophysiological process of CF, these patients 
require daily respiratory therapy, aiming to improve 
lung ventilation and mucociliary clearance through 
secretion removal4,5.
Airways clearance techniques are considered of 
great clinical benefit to reduce lung complications 
and their prescription is relevant to the clinical course 
of the disease in these patients6. Moreover, airway 
clearance techniques facilitate bronchial hygiene 
and, consequently, improve lung function, which is 
considered essential for optimizing respiratory status 
and reducing the progression of lung disease7. Self-
administered therapies as Positive Expiratory Pressure 
(PEP) are being used to promote greater independence 
to the patient8. Studies have shown that the use of PEP 
induces important benefits in blood gases concentration, 
aerosol particles deposition, expectoration, airflow, and, 
consequently, lung function9,10. However, PEP-induced 
changes on lung volumes are not fully established due 
to muscular limitations and consequent respiratory 
muscles asynchronous activity that may be present in 
children with CF11. Besides lung disorders, children 
with CF frequently show paradoxical or asynchronous 
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motion between chest wall and abdomen during 
breathing12-14. This alteration is related to disease 
severity, increased risk of respiratory failure, and poor 
prognosis in patients with obstructive disease15,16.
Therefore, the aim of this study was to compare the 
changes of different intensities of PEP on chest wall 
volumes and breathing pattern in children with CF 
and healthy controls. Chest wall volume analysis was 
performed by Optoelectronic Plethysmography (OEP), 
which can detect variations in motion and volume of 
the chest wall and its compartments during breathing, 
allowing the analysis and evaluation of these changes 
during rest and/or exercise17.
METHODOLOGY
Subjects
Subjects with CF diagnosis were recruited at 
the Cystic Fibrosis Multidisciplinary Clinic of a 
University Hospital. Age-matched healthy controls 
without previous history of cardiopulmonary disease 
were recruited in the community. Individuals of both 
genders, aged 7 years, able to perform acceptable 
evaluation exams, lung function, and respiratory muscle 
strength tests and with no postural disorders were 
included in the study. Subjects who presented disease 
exacerbation, such as hospitalization three weeks prior 
to data collection due to respiratory infection, used 
medication that could interfere in the exam results, 
such as short-term bronchodilator, and that did not 
complete all exams, quit or missed an appointment 
during the evaluation period were excluded from the 
study. This study was submitted and approved by the 
Research Ethics Committee of the University Hospital 
(number 497/10). All participants and their guardians 
were informed about the study and signed an Informed 
Consent form in accordance with the principles of the 
Helsinki declaration18.
Study design
This is a cross-sectional study performed in a 
single day at the Laboratory of PneumoCardioVascular 
and Respiratory Muscle Performance. Before sample 
collection, the study was explained to the individuals, 
who were then interviewed regarding their medical 
history and medication use. Anthropometric 
characteristics were assessed before data collection. 
Next, subjects underwent spirometry and respiratory 
muscle strength assessment. Lastly, chest wall volumes 
were assessed by Optoelectronic Plethysmography 
using two different intensities of PEP (10 and 
20 cm H2O). PEP intensity order randomization was 
performed manually by using a brown paper envelope. 
Room temperature during data collection was set 
between 22 and 24°C, with relative air humidity 
between 50 and 60%.
Anthropometric evaluation
Weight and height were determined using an 
anthropometric scale (Welmy, Santa Bárbara D’Oeste, 
São Paulo, Brazil). The values obtained were used 
to calculate Body Mass Index (BMI) (weight (kg)/
height2 (m)). Percentile values of BMI were used for 
anthropometric characterization according to the 
cutoff points recommended by the World Health 
Organization19.
Spirometry
The technical procedure, acceptability and 
reproducibility criteria, reference and interpretative 
values, as well as standardization and equipment 
followed the recommendations of the American 
Thoracic Society (ATS)/European Respiratory Society 
(ERS)20. Reference forced expiratory volume in the first 
second (FEV1), forced vital capacity (FVC), and FEV1/
FVC ratio were obtained by derivations from the pre-
established equations21. All procedures were performed 
in seated position. A DATOSPIR® 120 (Sibelmed, 
Barcelona, Spain) device, calibrated daily, was used.
Respiratory muscle strength
Respiratory muscle strength was assessed by maximal 
inspiratory pressure (MIP) and maximal expiratory 
pressure (MEP) using a MVD300 digital manometer 
(GlobalMed, Porto Alegre, Brazil). Measures were 
collected according to the recommendations of the 
American Thoracic Society/European Respiratory 
Society, using the reference values obtained for 
children22,23. Briefly, MIP was measured following 
maximal inspiration from residual volume with nasal 
nostril closed, while MEP was obtained through 
maximal expiration from total lung capacity in seated 
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position. A nozzle with a hole of approximately 1mmwas 
used to dissipate facial and oropharynx muscles pressure. 
Five to eight tests were performed until maximal values 
were reproducible.
Assessment of chest wall volumes and PEP
Optoelectronic pletysmography (OEP) (OEP® 
system, BTS, Milan, Italy) was used to evaluate chest 
wall and its compartments (Pulmonary Rib Cage – 
Rcp, Abdominal Rib Cage – Rca and Abdomen – 
Ab), volumes, and their variations during rest and 
different levels of PEP in both groups. All individuals 
were positioned in seated position on a backless 
bench and centralized in a system of six cameras 
previously calibrated according to the manufacturer’s 
recommendations and previously published studies24-26. 
Subjects were requested to remain motionless breathing 
freely for 180 seconds. After quiet breathing (QB), chest 
wall volumes was evaluated using two different PEP 
intensities (10 and 20 cm H2O), randomly chosen, using 
the Threshold PEP® independent flow device (Health 
Scan Products Inc. Cedar Grove, USA) for the same 
period of QB (180 seconds). A minimal resting period 
of 20 minutes between different intensities of PEP 
was given to subjects. After the data was acquired the 
most stable period of 30 seconds of each period was 
analyzed. We considered the following variables for 
analysis: total tidal volume, percentage contribution of 
the different chest wall compartments (RCp, RCa and 
AB) to tidal volume, minute ventilation, respiratory 
rate, inspiratory time (Tinsp), expiratory time (Texp), total 
respiratory cycle time, total and compartmental chest 
wall operating volumes, namely end-expiratory (EEV), 
and end-inspiratory (EIV) volumes. The changes in 
length of rib cage inspiratory muscle can be estimated 
by the relationship among Pulmonary Rib Cage 
volume variation and Inspiratory Time (VTrcp/Ti). 
The relationship can be used as a shortening velocity 
index of the rib cage inspiratory muscle 25.
Statistical analysis
Shapiro-Wilk normality test was applied to the 
variables. Two-way analysis of variance (ANOVA) 
with Bonferroni post hoc was performed to verify the 
differences between the variables’ means during quiet 
breathing and different PEP levels in the study groups. 
GraphPad Prism 5 software (GraphPad Software Inc. 
San Diego, California, USA) was used for the analysis, 
with significance level set at p>0.05. The effect size 
was calculated using the G*Power software (G*Power 
3.1.9.2, Kiel, Germany).
RESULTS
Fourteen subjects with CF and 12 healthy 
individuals were enrolled. Six subjects from CF group 
were excluded: three due to disease exacerbation prior 
to sample recruitment, two due to irregularities and 
artifacts originated during data collection, and one due 
to study withdrawal). As for the healthy controls, five 
were excluded: three due to irregularities and artifacts 
originated during data collection and two due to study 
withdrawal.
The mean, standard deviation and standard 
deviation difference of respiratory rate were considered 
to calculate the effect size. We found a Cohen’s d of 
1.4 considering a α error probability of less than 0.05 
(p>0.05) with 0.70 of power. The result found indicated 
a large effect size27. Ideal sample size calculated to the 
study was eight subjects per group.
Anthropometric characteristics
No significant difference was found regarding 
anthropometric characteristics between CF group and 
controls for age, gender, weight, and height (p>0.05). 
According to body mass index (BMI) percentile cutoff 
points, two subjects with CF (25%) showed values 
below those recommended for the age. In contrast, 
three (43%) controls showed BMI values above those 
recommended for the age at the moment of sample 
collection. All anthropometric characteristics are shown 
in Table 1.
Spirometry and maximal inspiratory/expiratory 
muscles pressures
CF group showed significantly lower lung function 
values for FEF25-75% and FEV1/FVC ratio when 
compared to the control group (p>0.05). Although CF 
patients showed slightly lower mean values for MEP 
compared to controls, neither inspiratory nor expiratory 
maximal pressures were significantly different between 
the groups (Table 1).
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Table 1. Anthropometric characteristics and lung function values
Cystic Fibrosis group
(n = 8)
Control group
(n = 7) p-value
Anthropometric characteristics
Gender (M/F) 5/3 4/3 1
Age (years) 11.5 ± 3.2 10.7 ± 1.5 0.55
Weight (kg) 32.1 ± 9.6 38.2 ± 7.8 0.20
Height (cm) 140 ± 12.8 143 ± 8.5 0.48
Lung function
FVC (l/s) 1.9 ± 0.5 2 ± 0.5 0.60
FVC (% pred) 84.3 ± 17.5 82.8 ± 11.9 0.84
FEV1 (l/s) 1.5 ± 0.4 2 ± 0.5 0.06
FEV1 (%pred) 72.7 ± 12.8 84.6 ± 14.4 0.11
FEF25-75% (l/s) 1.8 ± 0.8 2.3 ± 0.6 0.007
FEV1/FVC 0.8 ± 0.1 1 ± 0.1 0.01
FEV1/FVC (%) 81.5 ± 5.7 96.9 ± 13.5 0.01
MIP (cm H2O) 78.9 ± 25.6 85.3 ± 21.4 0.66
MIP (% pred) 85.5 ± 23.5 91.1 ± 21.2 0.39
MEP (cm H2O) 85.1 ± 25.9 109 ± 21.5 0.05
MEP (% pred) 84.4 ± 27.9 110.3 ± 24.57 0.15
*absolute values, values expressed in predicted percentage, p-value calculated using Fisher exact test for gender and unpaired t test for the other variables; FVC: Forced Vital Capacity; FEV1: Forced 
Expiratory Volume in the first second; FEF25-75%: Forced Expiratory Flow between 25 and 75% of the spirometric curve; VEF1/CVF% ratio expressed in percentage; MIP: Maximal inspiratory pressure; 
MEP: Maximal expiratory pressure.
Chest wall variations and breathing pattern during 
QB and PEP
Intragroup analysis showed that tidal volume values in 
chest wall and its compartments were higher during the 
use of different PEP levels compared to quiet breathing 
in both groups (p>0.05). Regarding PEP10, no significant 
difference was found in intergroup analysis. However, 
total and compartmental tidal volumes were significantly 
higher in controls compared to CF patients during PEP20 
(CW: 0.77 ± 0.25 L vs. 0.44 ± 0.16 L; RCp: 0.3 ± 0.13 L 
vs. 0.18 ± 0.1 L; RCa: 0.21 ± 0.1 L vs. 0.12 ± 0.1 L; AB: 
0.25 ± 0.1 L vs. 0.15 ± 0.1 L; p>0.05) (Figure 1).
Respiratory rate (RR, breaths/min) was significantly 
higher in the CF group (36.3±7, 33.8±14 and 37.8 ± 14.1 
during QB, PEP10 and PEP20, respectively) compared to 
controls (28.2 ± 5.1, 30.6 ± 17.1 and 24.3 ± 14.6, p>0.005). 
In both groups, minute ventilation (MV, L/min) was 
significantly higher during PEP10 (15.6 ± 7.6 vs 19.5 ± 9.2) 
and PEP20 (16.6 ± 8.1 vs 17.8 ± 9.6) in CF patients and 
controls, when compared to quiet breathing (QB: 10.4 ± 3.3 
vs. 8.1 ± 1.2, p>0.005). The increase in minute ventilation 
when using different intensities of PEP was obtained, 
however, by adopting different breathing patterns in the 
two groups (Figure 2A). While controls achieved increased 
ventilation with higher tidal volume (QB: 0.289 ± 0.062 L; 
PEP10: 0.719 ± 0.279 L; and PEP20: 0.755 ± 0.259 L) 
and lower respiratory rate during PEP20, CF children 
showed an inverse pattern with lower tidal volume (QB: 
0.292 ± 0.094 L; PEP10: 0.492 ± 0.169 L; and PEP20: 
0.442 ± 0.160 L) and higher respiratory rate (Figure 2A).
Correspondingly, during QB, PEP10 and PEP20, 
total respiratory cycle time (Ttot, seconds) was lower in 
CF patients compared to controls (p>0.02, figure 2B). 
In CF patients, inspiratory time (Tinsp, seconds) was 
significantly lower than controls during PEP20 (0.74 ± 0.2 
vs. 1.16 ± 0.54, p>0.05) and did not change regarding 
what we observed during spontaneous quiet breathing at 
rest. Expiratory time (Texp) did not change significantly 
during PEP compared to QB in both groups. Although 
there was no significant difference, Texp tended to be 
higher in controls and lower in CF patients during PEP 
compared to QB. The increase percentage of total and 
compartmental tidal volume regarding quiet breathing 
in resting conditions was slightly higher in controls than 
CF patients. During PEP10, the increase in CW, RCp, 
RCa and AB was 60%, 67%, 63%, and 48% in controls 
and 40%, 52%, 52%, and 13% in CF patients. During 
PEP20, the increase was 63%, 68%, 67%, and 52% in 
controls and 34%, 40%, 45%, and 18% in CF patients. The 
shortening velocity index of rib cage inspiratory muscle 
showed significant changes during PEP10 and PEP20 in 
the control group compared to baseline (p>0.05), without 
changes in intergroup analysis (Figure 2C).
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Figure 1. Volumes of chest wall and its compartments during quiet breathing and different levels of PEP in control group and CF
Values represent mean ± standard deviation. QB: quiet breathing; PEP10: positive expiratory pressure 10 cm H2O; PEP20: positive expiratory pressure 20 cm H2O. *p>0.05 ‒ PEP20 vs. QB (two-way 
ANOVA).
Figure 2. Breathing pattern and shortening velocity index of the rib cage inspiratory muscle of Values represent mean ± standard 
deviation. QB: Quiet breathing; PEP10: Positive expiratory pressure 10 cm H2O; PEP20: Positive expiratory pressure 20 cm H2O; Vtrcp/Ti: 
relation between pulmonary rib cage volume variation and inspiratory time. *p>0.05 (two-way ANOVA)
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Total and compartmental chest wall operating 
volumes during different intensities of PEP
End-expiratory volume (EEV) of total chest wall 
and pulmonary rib cage compartment significantly 
increased during the use of PEP (both intensities) 
compared to resting conditions (p>0.05) in both groups. 
Intergroup analysis did not show significant differences 
regarding EEV. End-inspiratory volume (EIV) was 
significantly increased in the rib cage pulmonary 
compartment during PEP compared to QB (p>0.01) 
(Figure 3).
Figure 3. Operating total and compartmental chest wall volumes during different intensities of PEP
Values represent mean ± standard deviation. A) CF group; B) Control group. QB: quiet breathing; PEP10: Positive expiratory pressure 10 cm H2O; PEP20: Positive expiratory pressure 20 cm H2O; EEV: End-
expiratory volume; EIV: End-inspiratory volume. *p>0.05 – PEP10 vs. QB; # p>0.01 – PEP10 vs. QB; § p>0.01 – PEP20 vs. QB; ¥ p>0.05 – PEP20 vs. QB. Two-way ANOVA. Bonferroni’s post hoc between moments
Fisioter Pesqui. 2017;24(3):311-320
318
When considering total and compartmental EIVs, 
intergroup analysis showed significant difference 
between CF and controls only at PEP20 for abdomen 
compartment (p>0.01, Figure 4).
Figure 4. End-inspiratory volume (EIV) in abdomen during 
different intensities of PEP
Values represent mean ± deviation. QB: Quiet breathing; PEP10: Positive expiratory pressure 10 
cmH2O; PEP20: Positive expiratory pressure 20 cmH2O. *p>0.01 (two-way ANOVA). Bonferroni’s 
post hoc between groups
DISCUSSION
Results showed that chest wall tidal volume 
increased during the use of PEP in comparison to quiet 
breathing. Moreover, the increase was significantly 
higher in controls compared to CF during PEP20. We 
also found that, compared to controls, children with CF 
are characterized by a more rapid and shallow breathing 
pattern, both during spontaneous quiet breathing at rest 
and during the use of PEP, as showed in Figure 2A. 
In addition, we have shown that minute ventilation 
increases in CF children during the use of PEP due to 
an increase of tidal volume. End-expiratory volume also 
increases compared to quiet breathing.
PEP is one of the most common airway clearance 
techniques used in different countries, such as Canada5. 
A recent study with 6,372 CF patients performed in the 
United Kingdom, showed that PEP was the third most 
popular technique used to manage patients’ conditions28. 
Despite its wide dissemination and use, little is known 
about its effects in ventilation. This feature is not related 
only to PEP, but all airway clearance techniques. The 
lack of knowledge about the physiological responses 
of airway clearance techniques was observed in the 
conclusion of five Cochrane systematic reviews that 
were inconclusive regarding the best airway clearance 
technique for CF patients5.
The acute effects of PEP have been previously 
studied in the literature. However, in the previous 
studies the possible dynamic changes in ventilation 
and breathing pattern were not assessed. Van Winden 
et al. (1998) studied the effects of flutter and PEP mask 
in symptoms and lung function in 22 CF patients29. 
The authors did not find any significant changes in lung 
function parameters after a single session or 2 weeks of 
PEP or flutter use. A recent study, by McIlwaine et al. 30, 
analyzed long-term efficacy of high frequency chest wall 
oscillation (HFCWO) in comparison to theraPEP in 
patients with CF30. The primary outcome was the number 
of pulmonary exacerbations. The authors found no 
significant difference in quality of life and lung function 
between the groups. PEP showed to be more efficient 
in terms of time of use and number of exacerbations 
(1.14 for PEP vs 2.0 for HFCWO). A great number of 
CF studies aim to compare airway clearance techniques. 
On the other hand, we consider that is more important 
to first understand the mechanisms and how patients 
respond to each technique, in this case, PEP.
To our knowledge, this is the first study that evaluated 
the acute effects of PEP in the volumes of chest wall 
and its compartments in CF children. For this propose, 
we have used Optoelectronic Plethysmography, which 
provides continuous dynamic measurements of volume 
variations of the chest wall, divided into compartments17. 
Our results showed a rapid and shallow breathing 
pattern at rest and during use of different intensities 
of PEP in children with CF. Even though minute 
ventilation was similar between groups, CF patients 
showed less efficient breathing patterns compared to 
controls, as observed by the increased respiratory rate 
(at rest and during PEP use) and a decreased tidal 
volume during PEP use.
In fact, the use of PEP in Cystic Fibrosis and 
controls showed an increase in minute ventilation, 
compared to quiet breathing. The mechanism that 
leads to this increase, however, differs between groups, 
at least at the highest level of PEP considered in the 
study. While in controls the increase in ventilation 
was due to a significant increase of tidal volume when 
both PEP10 and PEP20, were applied, in CF subjects 
the tidal volume significantly increased only during 
the application of PEP10,while at PEP20 an increase of 
respiratory rate was observed. A clinical implication of 
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our findings is, therefore, that high levels of PEP should 
not be used in children with CF, to avoid overloading 
respiratory muscles to overcome the load imposed by 
the use of PEP.
There is still a lack of studies showing respiratory 
strength impairment in subjects with CF in the literature. 
Published data in the same topic are also controversial, 
however, we may speculate that individuals with CF 
show difficulty in overcoming a pressure load of 20 
cmH2O due to reduction of the strength of expiratory 
muscles, as shown by the lower values of maximal 
expiratory pressure (MEP: 83.1 ± 25.9 vs. 109 ± 21.5 
for CF and control groups, respectively), compared to 
controls, found in this study.
We may hypothesize that the increase in end-
expiratory volume observed during PEP may be 
beneficial, particularly in those children in which the 
restrictive pattern is prevalent. On the other hand, 
in those children in which the obstructive pattern is 
prevalent, the EEV increase induced by PEP could 
not be clinically interesting as these subjects present 
pulmonary hyperinflation due to air trapping in the 
lungs, which was maintained.
We believe that the main limitation of our study is 
the small sample of participants and extrapolation of 
the results should be done carefully. However, CF is not 
a common lung disease, therefore, its low prevalence 
makes the recruitment of individuals even more limited.
CONCLUSION
In conclusion, different levels of PEP induce an 
increase of chest wall volumes in CF children with 
different mechanisms compared to controls. Even with 
the improvement caused by PEP, CF children still show 
shallow breathing characteristics. PEP levels above 
10 cm H2O should be used with caution in CF children.
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